Antimicrobial susceptibility testing with EUCAST breakpoints and methods
Update on EUCAST 2014
Update on EUCAST methods and breakpoints
Internal quality control
External quality assessment
Susceptibility testing systems - are some more equal than others?
Issues in testing susceptibility to beta-lactam / beta-lactamase inhibitor combinations Susceptibility testing of infrequently isolated fastidious organisms
Moderated panel discussion on questions from the audience
Co-Organiser: EUCAST

Bloodstream infections: opportunities for outcome improvement
Rapid diagnostic tests and early reporting
Clinical evaluation and management
Optimising therapy
Bacteraemia in difficult patients
Co-Organiser: ESGBIS

When is a food-borne infection not a food-borne infection?
Risky reptiles and perilous pets: food-borne pathogens acquired from companion animals
Norovirus: kitchen hygiene versus hand hygiene
Tracking down toxoplasmosis
Campylobacter: do not just blame the chickens
Co-Organiser: EFWISG

Basics of infections in travellers
Infections with a long incubation period in returning travellers
Imported malaria in Europe - migrants and visiting-friends-and-relatives travellers as high risk groups
Misinterpretation of symptoms and overlooked illnesses in migrants - differentials to infections (case discussion)
Fever in returning travellers (case discussion)
Co-Organiser: ESGITM

Recent research in critically ill patients: hands-on evidence
Advances in randomised control trials on candidaemia
How molecular biology is changing the diagnosis of respiratory infections in critically ill patients
A critical review of new biomarkers in VAP/HAP/SCAP
Time is changing: monitoring VAP, VAT or IVAC?
Co-Organiser: ESGCIP

Tuberculosis and other mycobacterial infections in low-income countries
How to diagnose mycobacterial infections in low-income countries
Strategy for TB treatment and management in migrants
Mycobacterial infections in HIV-positive patients in low-income countries
Leprosy and Buruli ulcer in Africa
Co-Organiser: ESGMYC

Tick-borne diseases prevalent in Europe
Human granulocytic anaplasmosis in Europe
Human babesiosis in Europe
Tick-borne encephalitis: what doctors need to know about this disease
Treatment regimens for Lyme neuroborreliosis within the sway of antibiotic maximalism
Co-Organiser: ESCAR, ESGBOR

Update on anaerobes: new methods bring new information about the bugs and their importance in health and disease
What is hidden behind the name? Why taxonomic changes are key to elucidating  the role of anaerobic pathogens
"User friendly" identification of anaerobes: the role of MALDI-TOF
Does antibiotic resistance exist in anaerobic bacteria? Disk diffusion for antimicrobial susceptibility testing and beyond
Who would believe it? The unexpected role of anaerobes in a variety of conditions
Co-Organiser: ESGAI, TAE

Human parasites of the gut: epidemiology and diagnostic approaches in the molecular era
General introduction and epidemiology of common parasites of the human gut
Classical diagnostic methods for detection of parasites
Detection of parasites with molecular methods
Molecular typing of parasites
Co-Organiser: ESGCP, ESGMD

Diagnosis and treatment of Helicobacter pylori infection. What is new in 2014?
Real-time PCR for H. pylori diagnosis. Better than culture?
MALDI-TOF mass spectrometry applied to H. pylori diagnosis and typing
Lessons from the study of gastric microbiota
Sequential therapy or pylera(R) to eradicate H. pylori
Co-Organiser: EHSG

Infection prevention and management in long-term care facilities
Antibiotic-resistant bacteria in elderly facilities: good news and pitfalls
Implications of MDR control in different types of long-term care facilities: should infection control limit daily activities?
Clostridium difficile infection in the elderly
Challenges, strategies and research priorities of antimicrobial stewardship programmes in LTCFs for the elderly
Co-Organiser: ESGAP, ESGIE, ESGNI

ESCMID guidelines for diagnosis and treatment of Aspergillus diseases
Diagnostic procedures
Invasive aspergillosis in children
Invasive aspergillosis in haematology and oncology
Non-invasive aspergillosis
Co-Organiser: EFISG, ESGICH, European Confederation of Medical Mycology (ECMM), European Respiratory Society (ERS) and European Academy of Allergy and Clinical Immunology (EACCI)

Management of ocular parasitic diseases
Ocular acanthamoebiasis
Ocular larva migrans, cysticercosis, dirofilariasis
Ocular toxoplasmosis
Diagnosis of ocular parasites
Co-Organiser: ESGCP

How to prevent the consequences of EBV infection in transplant recipients?
Dynamics of EBV viraemia and its relationship with the development of PTLD
Which population should be monitored?
Is there any role of antivirals and rituximab in the pre-emptive management of PTLD?
Role of reduction of immunosuppression, immune-adoptive therapy and other measures
Co-Organiser: ESGICH

Elderly and chronic hepatitis C - to treat or not to treat?
What a difference the age makes? Clinical course of chronic hepatitis C in the elderly
Treatment of chronic hepatitis C in the elderly - are we missing opportunities?
Management of chronic hepatitis C in the elderly not eligible for standard treatment
Elderly with chronic hepatitis C in real-life setting
Co-Organiser: Group of ESCMID ID members interested in viral hepatitis

Viral infections in pregnancy
Hepatitis B in pregnancy
Hepatitis C in pregnancy
Prevention of mother to child transmission of HIV
Hepatitis E in pregnancy
Co-Organiser: ESGVH

How to diagnose and treat bacterial and fungal biofilm infections
Fungal biofilm diagnosis
Fungal biofilm treatment
Bacterial biofilm diagnosis
Bacterial biofilm treatment
Co-Organiser: ESGB

Basic concepts of pharmacokinetics and pharmacodynamics
Basic concepts of PK/PD
Translating PK/PD concepts into dosing strategies
Optimising therapy in obese and frail patients
Optimising therapy to minimise emergence of resistance
Co-Organiser: EPASG

Vaccination in the elderly: perspectives
Immune senescence: impact on vaccination efficacy
New and old vaccines for the elderly
Vaccination in elderly: the need of a life-course programme
Vaccine coverage in elderly population in Europe
Co-Organiser: ESGIE, EVASG

Follow ECCMID on

LinkedIn